Artivion | CRY - Interest Expense On Debt

Stock Price
38.33
Daily Change
0.33 0.87%
Monthly
-13.50%
Yearly
35.63%
Q1 Forecast
37.14

Artivion reported $7.83M in Interest Expense on Debt for its fiscal quarter ending in March of 2024.





Interest Expense On Debt Change Date
Abbott USD 42M 2M Dec/2025
Accuray USD 2.88M 72K Dec/2024
AngioDynamics USD 100K 134K Feb/2025
Artivion USD 7.83M 1.22M Mar/2024
AtriCure USD 1.33M 17K Sep/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Boston Scientific USD 90M 3M Dec/2025
Edwards Lifesciences USD 38.6M 1.2M Sep/2025
Inogen 1.03M 384K Mar/2025
Integra LifeSciences USD 22.72M 1.68M Sep/2025
J&J USD 18M 290M Sep/2025
Mesa Laboratories USD 3.02M 180K Sep/2024
Orthofix International 5.2M 4.71M Sep/2024
Pfizer USD 711M 59M Dec/2025
ResMed USD 8.79M 14.55M Sep/2025
Stryker USD 157M 46.17B Sep/2025
Surmodics USD 884K 5K Sep/2024
Tandem Diabetes Care USD 2.07M 872.58M Dec/2025
Teleflex USD 31.84M 10.13M Sep/2025
Terumo JPY 463M 445M Dec/2025
Trinity Biotech USD 3.33M 50K Sep/2025